Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance
✍ Scribed by Mohammed Al Otaibi; Philip Ross; Nader Fahmy; Suganthiny Jeyaganth; Helen Trottier; Kanishka Sircar; Louis R. Bégin; Luis Souhami; Wassim Kassouf; Armen Aprikian; Simon Tanguay
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 141 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND: Risk models to predict prostate cancer on biopsy, whether they include only prostate‐specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening hi
## BACKGROUND. Information regarding the quantity of biopsy material invaded by cancer may supplement the usual criteria for the preoperative staging of patients suffering from clinically localized prostate carcinoma (T1 -T2). However, conflicting conclusions have been drawn and this topic needs f
## Abstract ## Purpose To assess the presence of extraprostatic extension and seminal vesicle invasion in men with prostate cancer, we performed systematic staging biopsies targeting neurovascular bundles, seminal vesicles, and other extraprostatic tissues before the men underwent radical prostate
## Abstract This study reports the outcome of active surveillance in men with PSA screening‐detected prostate cancer (PC), and PSA doubling time (PSADT) was evaluated as a predictor of selecting patients to active treatment or surveillance. On December 31, 1994, 10,000 men were randomized to bienni